Search

Search Constraints

You searched for: Author/Creator Domingo, Enric

Search Results

1. A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS. Issue 1 (19th March 2014)

2. A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment. Issue 10 (1st September 2020)

4. Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial. Issue 11 (November 2016)

5. Alternative splicing of TIA‐1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance. Issue 1 (20th August 2014)

6. Area at risk and collateral circulation in a first acute myocardial infarction with occluded culprit artery. STEMI vs non-STEMI patients. (15th May 2018)

7. Can an ultrathin strut stent design and a polymer free, proendothelializing probucol matrix coating improve early strut healing? The FRIENDLY-OCT trial. An intra-patient randomized study with OCT, evaluating early strut coverage of a novel probucol coated polymer-free and ultra-thin strut sirolimus-eluting stent compared to a biodegradable polymer sirolimus-eluting stent. (1st August 2022)

8. Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy. Issue 9 (22nd September 2022)

9. Deep learning for prediction of colorectal cancer outcome: a discovery and validation study. Issue 10221 (1st February 2020)

10. Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification. Issue 6 (28th September 2019)